Literature DB >> 11350930

Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2.

U S Singh1, M T Kunar, Y L Kao, K M Baker.   

Abstract

Transamidation is a post-translational modification of proteins mediated by tissue transglutaminase II (TGase), a GTP-binding protein, participating in signal transduction pathways as a non-conventional G-protein. Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity). Transamidated RhoA functions as a constitutively active G-protein, showing increased binding to its downstream target, RhoA-associated kinase-2 (ROCK-2). Upon binding to RhoA, ROCK-2 becomes autophosphorylated and demonstrates stimulated kinase activity. The RA-stimulated interaction between RhoA and ROCK-2 is blocked by MDC and TGaseM, indicating a role for transglutaminase activity in the interaction. Biochemical effects of TGase activation, coupled with the formation of stress fibers and focal adhesion complexes, are proposed to have a significant role in cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350930      PMCID: PMC125450          DOI: 10.1093/emboj/20.10.2413

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  61 in total

Review 1.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

2.  Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors.

Authors:  K L Pierce; S Maudsley; Y Daaka; L M Luttrell; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

3.  Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis.

Authors:  M A Antonyak; U S Singh; D A Lee; J E Boehm; C Combs; M M Zgola; R L Page; R A Cerione
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

4.  The mixed lineage kinase DLK is oligomerized by tissue transglutaminase during apoptosis.

Authors:  S S Hébert; A Daviau; G Grondin; M Latreille; R A Aubin; R Blouin
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

5.  Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells.

Authors:  H Ou; J Haendeler; M R Aebly; L A Kelly; B C Cholewa; G Koike; A Kwitek-Black; H J Jacob; B C Berk; J M Miano
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367

6.  Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.

Authors:  B P Klaholz; A Mitschler; D Moras
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

Review 7.  Rho GTPases: signaling, migration, and invasion.

Authors:  A A Schmitz; E E Govek; B Böttner; L Van Aelst
Journal:  Exp Cell Res       Date:  2000-11-25       Impact factor: 3.905

8.  Differential ligand-dependent protein-protein interactions between nuclear receptors and a neuronal-specific cofactor.

Authors:  E F Greiner; J Kirfel; H Greschik; D Huang; P Becker; J P Kapfhammer; R Schüle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

9.  Structure at 1.65 A of RhoA and its GTPase-activating protein in complex with a transition-state analogue.

Authors:  K Rittinger; P A Walker; J F Eccleston; S J Smerdon; S J Gamblin
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

10.  Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization.

Authors:  C P Mack; A V Somlyo; M Hautmann; A P Somlyo; G K Owens
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

View more
  22 in total

Review 1.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

Review 2.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 3.  Diabetic complications in pregnancy: is resveratrol a solution?

Authors:  Chandra K Singh; Ambrish Kumar; Holly A Lavoie; Donald J Dipette; Ugra S Singh
Journal:  Exp Biol Med (Maywood)       Date:  2013-05-29

4.  Positional cloning and next-generation sequencing identified a TGM6 mutation in a large Chinese pedigree with acute myeloid leukaemia.

Authors:  Li-Li Pan; Yuan-mao Huang; Min Wang; Xiao-e Zhuang; Dong-feng Luo; Shi-cheng Guo; Zhi-shun Zhang; Qing Huang; Sheng-long Lin; Shao-yuan Wang
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

5.  Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway.

Authors:  Anna Janiak; Evgeny A Zemskov; Alexey M Belkin
Journal:  Mol Biol Cell       Date:  2006-02-01       Impact factor: 4.138

6.  Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2.

Authors:  Zsolt Keresztessy; Eva Csosz; Jolán Hársfalvi; Krisztián Csomós; Joe Gray; Robert N Lightowlers; Jeremy H Lakey; Zoltán Balajthy; László Fésüs
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

7.  Transglutaminase-1 regulates renal epithelial cell proliferation through activation of Stat-3.

Authors:  Zhu Zhang; Jingping Xing; Li Ma; Rujun Gong; Y Eugene Chin; Shougang Zhuang
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

8.  Transglutaminase 2 regulates the GTPase-activating activity of Bcr.

Authors:  Sun-Ju Yi; John Groffen; Nora Heisterkamp
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 9.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

10.  Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA.

Authors:  Essi Myrsky; Sergio Caja; Zsofi Simon-Vecsei; Ilma R Korponay-Szabo; Cristina Nadalutti; Russell Collighan; Alexandre Mongeot; Martin Griffin; Markku Mäki; Katri Kaukinen; Katri Lindfors
Journal:  Cell Mol Life Sci       Date:  2009-08-13       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.